21/09/2026
New PET scan to measure glioma tumour activity.
Not sure if this new type of PET scan is specifically for glioblastoma or all gliomas, but an interesting development.
Source:
https://www.ucsf.edu/news/2026/09/432576/fda-approves-pet-imaging-agent-brain-cancer-based-ucsf-data?fbclid=IwdGRjcAUdx8xwZG9mBWZkaWQWUO1v0BC2gYwHqWrkC_TiZaY1sh7jcGV4dG4DYWVtAjExAHNydGMGYXBwX2lkCjY2Mjg1NjgzNzkAAR6WxE7pE3OuJ6lCFs0jzoLlKK0MtYGu6TOvSnbmdhcnsrWsGyvAUqqJokUgBA_aem_Fq-WnjKuaawV-YOHiLHjzA
UC San Francisco study data was instrumental in today’s approval by the Food and Drug Administration (FDA) of a PET imaging agent that helps physicians evaluate gliomas, a form of brain cancer.The approval of floretyrosine F 18 (18F-FET) was supported by prospective clinical trial data generated a...